News Conference News ESC 2016 NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry Michael O'Riordan August 28, 2016
News Daily News FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors Michael O'Riordan August 18, 2016
News Daily News A la Larga el Control de la Warfarina es Complicado Incluso en Pacientes Inicialmente Inestables Todd Neale August 10, 2016
News Daily News Warfarin Control Over Time Is Shaky Even in Those Who Are Initially Stable Todd Neale August 10, 2016
News Daily News Study Provides More Evidence That Having A-fib Ups Risk of Developing Dementia L.A. McKeown July 19, 2016
News Daily News Rivaroxaban podría Ayudar a Disolver Trombos Auriculares Izdos. en Pacientes con FA Todd Neale June 09, 2016
News Daily News Rivaroxaban May Help Dissolve Left Atrial Thrombus in Patients With A-fib Todd Neale June 09, 2016
News Conference News EuroPCR 2016 EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy Yael L. Maxwell May 17, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2016 Shelley Wood April 29, 2016
News Daily News Good Warfarin Management Prevents Complications in A-fib Patients, Swedish Study Contends L.A. McKeown April 21, 2016
Presentation Scripps 2016 Putting It All Together: Warfarin, NOAC or LAA Closure? Presenter: Brian K. Whisenant February 04, 2016
News Daily News In the Real World, Dabigatran and Warfarin Give Equal Stroke Protection to A-fib Patients Todd Neale January 25, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular News Stories for 2015 Shelley Wood December 29, 2015
News Opinion Editor's Corner Las 10 Noticias de TCTMD Más Leídas de 2015 Shelley Wood December 29, 2015
News Daily News Un Estudio Confirma la Rentabilidad del Dispositivo Watchman para el Cierre del AAI en el Descenso de ACV L.A. McKeown December 14, 2015
News Daily News Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction L.A. McKeown December 14, 2015
Presentation Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure Presenter: Vivek Y. Reddy December 13, 2015